Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.

The team, which included senior researchers in epidemiology, health economics and orthopaedic surgery, used routinely-collected hospital and primary care data from patients who had a knee replacement or a hip replacement in England, assessing over 10,000 patients for each procedure.

With healthcare budgets stretched, the provision of knee and hip replacements has come under increased pressure in the NHS. One result is that access to these surgeries has been restricted, and a number of clinical commissioning groups (CCGs) are currently limiting access based on patient's BMI and smoking status. In 2015, 22% of CCGs had a mandatory policy for knee and replacement regarding BMI, varying their cut-offs from a BMI of 30 to 40, and 4% of CCGs had mandatory policies requiring smoking cessation.

"Our findings, along with those from previous research, suggest that there is little evidence to support the rationing of knee and hip replacement based on individuals' BMI or smoking" said Ed Burn, DPhil student at the University of Oxford. "While there are many benefits from losing weight if overweight and stopping smoking, there seems to be little justification in limiting access to knee and hip replacement until such changes are made".

Previous research had already shown that BMI and smoking have little effect on patient reported outcomes after knee and hip replacement, but may be associated with a slight increase in the risk of post-operative complications.

Revision procedures are where implant components are removed, added, or exchanged. Revisions are an enduring risk, are more costly than primary procedures, and are associated with reductions in patient quality of life.

Funder

NIHR logo

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).